---
title: "Hydrafacial Expands Treatment Personalization and Elevates Results with Two New Treatment Enhancers"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298326655.md"
description: "SkinHealth Systems, headquartered in Long Beach, California, revealed on September 08, 2026, the introduction of two new products to their Hydrafacial line. The company behind Hydrafacial, traded as SKIN on Nasdaq, unveiled HydraGlow Pre-Extraction Peel and Hydralock HA Biocellulose Mask as the latest additions to their skincare range."
datetime: "2026-09-08T13:02:25.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298326655.md)
  - [en](https://longbridge.com/en/news/298326655.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298326655.md)
generator: "portal-rs"
---

# Hydrafacial Expands Treatment Personalization and Elevates Results with Two New Treatment Enhancers

SkinHealth Systems, headquartered in Long Beach, California, revealed on September 08, 2026, the introduction of two new products to their Hydrafacial line. The company behind Hydrafacial, traded as SKIN on Nasdaq, unveiled HydraGlow Pre-Extraction Peel and Hydralock HA Biocellulose Mask as the latest additions to their skincare range.

### Related Stocks

- [SKIN.US](https://longbridge.com/en/quote/SKIN.US.md)

## Related News & Research

- [SkinHealth Systems repays outstanding convertible notes principal of $103.24 million ahead of maturity](https://longbridge.com/en/news/301072111.md)
- [Hydrafacial Introduces HydraScalp® with Keravive™ as Next Evolution in Scalp Health | SKIN Stock News](https://longbridge.com/en/news/288420943.md)
- [Intel to keep working on Musk's Terafab chipmaking venture, Bloomberg News reports](https://longbridge.com/en/news/301101819.md)
- [Elon Musk and Intel CEO shore up chipmaker's role in Terafab project - and here's what the news is doing to the stock.](https://longbridge.com/en/news/301130383.md)
- [Musk says TSMC won't run Terafab AI chip complex](https://longbridge.com/en/news/301113398.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**